Yüklüyor......
Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients – yes, but how?
Abstract. In 2005, a seminal paper showed that glioblastoma patients aged 18 to 70, whose tumors have a methylated MGMT promoter have a better prognosis than patients with tumors carrying an unmethylated MGMT promoter. As a consequence of this and several confirmatory studies, routine MGMT testing i...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dustri-Verlag Dr. Karl Feistle
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3663470/ https://ncbi.nlm.nih.gov/pubmed/23083460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300576 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|